A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA

While Alzheimer's disease researchers continue to debate the underlying cause(s) of the disease, most agree that a diverse, multi-target approach to treatment will be necessary. To this end, the Alzheimer's Drug Discovery Foundation (ADDF) recently hosted the 11th International Conference...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Linda H, Shineman, Diana W, Fillit, Howard M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031879/
https://www.ncbi.nlm.nih.gov/pubmed/21159211
http://dx.doi.org/10.1186/alzrt57
Descripción
Sumario:While Alzheimer's disease researchers continue to debate the underlying cause(s) of the disease, most agree that a diverse, multi-target approach to treatment will be necessary. To this end, the Alzheimer's Drug Discovery Foundation (ADDF) recently hosted the 11th International Conference on Alzheimer's Drug Discovery to highlight the array of exciting efforts from the ADDF's funded investigators.

Ejemplares similares